Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring

• Main Authors: Pier Giorgio Cojutti (Author), Giacomo Fornaro (Author), Milo Gatti (Author), Matteo Rinaldi (Author), Paolo Gaibani (Author), Maddalena Giannella (Author), Federico Pea (Author), Pierluigi Viale (Author)
• Format: Book
• Published: MDPI AG, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bacteremia and ventilator-associated pneumonia due to a pan-resistant <i>Klebsiella pneumoniae</i> strain co-producing KPC and OXA-48 carbapenemases was successfully treated in a COVID-19 critically ill patient with a combination therapy of a high-dose continuous infusion of meropenem (u...